09:00 – 09:10 Welcome
Gustavs Latkovskis, Chairman of the Baltic Atherosclerosis Congress,
President-Elect of the Baltic Atherosclerosis Society
Zita Kucinskiene, President of the Baltic Atherosclerosis Society

SESSION 1
Burden and pathobiology of atherosclerosis
09:10 – 09:30  Burden of atherosclerotic diseases in the Baltic States. Vilnis Dzerve (Latvia)
09:30 – 10:00  Understanding atherosclerosis: a historic perspective. Kristaps Zarins (USA)
10:00 – 10:20  Current concepts of plaque instability and neoatherosclerosis.
Andrejs Erglis (Latvia)
10:20 – 10:40  New concepts derived from genome wide analyses. Siim Sober (Estonia)

10:40 – 11:00 Coffee break

11:00 – 11:10 Welcome address
Ingrida Circene, Minister of Health of Latvia
Andrejs Erglis, President of the Latvian Society of Cardiology,
Co-Chairman of the Baltic Atherosclerosis Congress

SESSION 2
Risk estimation for primary prevention
11:10 – 11:40  Challenges of risk estimation in primary prevention. Zeljko Reiner (Croatia)
11:40 – 12:00  Advantages and disadvantages of the risk prediction models.
Karl Andersen (Iceland)
12:00 – 12:20  Arterial markers of early atherosclerosis: clinical relevance and prognostic value. Ligita Ryliskyte (Lithuania)
12:20 – 12:40  Novel imaging techniques of atherosclerosis hemodynamic assessment.
Kristaps Zarins (USA)
12:40 – 13:00  Are we ready to incorporate genes in risk estimation? Lithuanian way towards genomics of coronary heart disease. Ingrida Domarkiene (Lithuania)

13:00 – 14:00 Lunch

SESSION 3
Management of dyslipidimias
14:00 – 14:30  Familial hypercholesterolemia: cascade screening and clinical implications.
G. Kees Hovingh (The Netherlands)
14:30 – 14:50  LDL-C goals as the mainstay of prevention. Gustavs Latkovskis (Latvia)
14:50 – 15:10  Statin side effects and safety. Rimvydas Slapikas (Lithuania)
15:10 – 15:30  Do we care about Lp{a} and Lp-PLA2? Edwin Blumberg (USA)

15:30 – 15:50 Coffee break

SESSION 4
Management of dyslipidemias
15:50 – 16:20  Emerging therapies of dyslipidemias. G. Kees Hovingh (The Netherlands)
16:20 – 16:40  Update on niacin and fibrates. Anu Hedman (Estonia)
16:40 – 17:00  Omega-3 fatty acids. Edwin Blumberg (USA)
17:00 – 17:20  Understanding HDL. Gustavs Latkovskis (Latvia)

17:20 – 17:30  Elections of the board of the Baltic Atherosclerosis Society

17:30               Welcome reception

SESSION 5
Lifestyle and traditional risk factors
08:30 – 08:45  High-risk vs. population based strategy for cardiovascular prevention.
Karl Andersen (Iceland)
08:45 – 09:00  What is new in the European Hypertension Society 2013 guidelines?
Margus Viigimaa (Estonia)
09:00 – 09:15  Are all antihypertensive drugs equal? Gustavs Latkovskis (Latvia)
09:15 – 09:30  Diabetes – targets and means, individualized approach. Valdis Pirags (Latvia)
09:30 – 09:45  CVD risk factors perception and reality in different subpopulations – physicians, medical students, general population, elderly. Zeljko Reiner (Croatia)
09:45 – 10:00  Evidence-based lifestyle changes and nutrition. Iveta Mintale (Latvia)

10:30 – 10:50 Coffee break

SESSION 6
Novel risk factors and targets
10:20 – 10:35  L-carnitine and atherosclerosis: a new potential therapeutic target.
Maija Dambrova (Latvia)
10:35 – 10:50  Cardiovascular risk and prevention in patients with chronic kidney disease. Marius Miglinas (Lithuania)
10:50 – 11:05  Vitamin D, calcium metabolism and cardiovascular risk. 
Virginijus Sapoka, Andrius Bleizgys (Lithuania)
11:05 – 11:20  Thyroid dysfunction and cardiovascular disease. Anu Ambos (Estonia)
11:20 – 11:35  Role of polyphenols in cardiovascular disease. Andrejs Erglis (Latvia)
11:35 – 11:50  Why lycopene is beneficial against cardiovascular disease?
Asta Mazeikiene (Lithuania)

12:20 – 12:30 ADJOURN

Download the Baltic Atherosclerosis Congress flyer here